At the Rosenman Institute we’re here to support medtech startups. We connect entrepreneurs to the resources and expertise they need to commercialize their technologies. Helping innovators forge connections is why we’ve brought our legendary symposium back for a fourth year. Join us in San Francisco on June 21 to learn from leaders in the field, meet CEOs of exciting early-stage companies, and get insight on how industry forms strategic partnerships with startups.
During the symposium, we'll hear lightning presentations from 10 entrepreneurs: the Rosenman Innovators. The Rosenman Innovators are the entrepreneurs selected as finalists for the Medtech Track of the QB3 Life Science Pitch Summits. Rosenman Innovators are eligible to be chosen to receive a wide range of valuable medtech services (valued at $250k) including lab time, prototyping, and design support, plus cash prizes. Learn more
1:00 pm Registration
1:30 pm Welcome: Christine Winoto, Deputy Director, QB3; Director, Rosenman Institute
1:35 pm Steve Hetts, UCSF: "Hitting Cancer Hard While Limiting Collateral Damage"
1:55 pm Company Demos: 2017 Rosenman Innovators
2:05 pm Justin Roberts, Medtronic: "TAVR: Developing and Cultivating a Breakthrough Therapy"
2:25 pm Company Demos: 2017 Rosenman Innovators
2:35 pm Break
3:00 pm Robert Gaunt, University of Pittsburgh: "Wired Brains: Technology & Neuroscience for Rehabilitation"
3:20 pm Company Demos: 2017 Rosenman Innovators
3:30 pm Richard Rapoza, Abbott Vascular: "Unexpected Consequences in Clinical Trial Design"
3:50 pm Showcase: Rosenman Innovation Award Startups
4:00 pm Break
4:30 pm Panel Discussion: "Game of Thrones: Strategic Acquisition in Medtech"
Lisa Suennen, GE Ventures (moderator)
Jennifer Kozak, Johnson & Johnson
Chris Eso, Medtronic
Virginia Giddings, Stryker
5:30 pm Reception